We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Consensus and Guidelines · May 15, 2022

EHA Guidelines for Antifungal Prophylaxis in Adult Patients With AML Treated With Novel Targeted Therapies

The Lancet Haematology

 

Additional Info

Disclosure statements are available on the authors' profiles:

The Lancet Haematology
Antifungal prophylaxis in adult patients with acute myeloid leukaemia treated with novel targeted therapies: a systematic review and expert consensus recommendation from the European Hematology Association
Lancet Haematol 2022 May 01;9(5)e361-e373, J Stemler, N de Jonge, N Skoetz, J Sinkó, RJ Brüggemann, A Busca, R Ben-Ami, Z Ráčil, V Piechotta, R Lewis, OA Cornely

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading